Importantly, a negative prognostic role of IDO1+ cells in SLN of patients with melanoma has been reported [13] according to previous hypotheses that IDO1 expression represents a melanoma immune escape mechanism [13,14]. This evidence concerns the gene IDO1 and melanoma.